ThornGWLaulerDP. Clinical therapeutics of adrenal disorders. Am J Med1972; 53: 673–84.
2.
EstebanNVLoughlinTYergeyALZawadkiJKBoothJDWintererJCDaily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab1991; 71: 39–45.
3.
ZelissenPMJCroughsRJMvan RijkPPRay-MakersJA. Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison's disease. Ann Int Med1994; 120: 207–10.
4.
FlorkowskiCMHolmesSJElliottJRDonaldRAEspinerEA. Bone mineral density is reduced in female but not male subjects with Addison's disease. N Z Med J1994; 107: 52–3.
5.
PeaceySRGuoC-Y.RobinsonAMPriceAGilesMAEastallRGlucocorticoid replacement therapy: Are patients over treated and does it matter?Clin Endocrinol1997; 46: 255–61.
6.
Al-ShoumerKASBeshyahSANiththyananthanRJohnstonDG. Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults. Clin Endocrinol1995; 42: 85–90.
7.
GarbeELeLorierJBolvinJ-FSuissaS.Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet1997; 350: 979–82.
8.
ScottRSDonaldRAEspinerEA. Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy. Clin Endocrinol1978; 9: 571–6.
9.
FeekCMRatcliffeJGSethJGrayCEToftADIrvineWJ. Patterns of plasma cortisol in patients with Addison's disease treated with conventional corticosteroid replacement. Clin Endocrinol1981; 14: 451–8.
10.
MullenPEJeffcoateWJLinsellCHowardRReesLH. The circadian variation of immunoreactive lipotrophin and its relation to ACTH and growth hormone in man. Clin Endocrinol1979; 11: 533–9.
11.
TrainerPJEastmentCGrossmanAGWheelerMJPerryLBesserGM. The relationship between cortisol production rate and serial serum cortisol estimation in patients on medical therapy for Cushing's syndrome. Clin Endocrinol1993; 39: 441–3.
12.
WeaverJUThaventhiranLNoonanKBurrinJMTaylorNFNormanMRThe effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clin Endocrinol1994; 41: 639–48.
WalkerBRAndrewRMacLeodKMPadfieldP.Growth hormone replacement inhibits renal and hepatic 11β-hydroxysteroid dehydrogenases in ACTH deficient patients. Clin Endocrinol1998; 49: 257–63.
15.
BurchWM. Urine free-cortisol determination: A useful tool in the management of chronic hypoadrenal states. JAMA1982; 247: 2002–4.
16.
HowlettTA. An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol1997; 46: 263–8.
17.
BesserGMJeffcoateWJ. Endocrine and metabolic diseases: Adrenal diseases. BMJ1976; 1: 448–51.
18.
StewartPMCorrieJSecklJREdwardsCRPadfieldPL. A rational approach for assessing the hypothalamic-pituitary-adrenal axis. Lancet1988; i: 1208–10.
19.
WoodPJ. Short Synacthen tests – the need for rationalization. Clin Endocrinol1998; 49: 283.
20.
ClarkPMNeylonIRaggattPRSheppardMCStewartPM. Defining the normal cortisol response to the short Synacthen test: Implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol1998; 49: 287–92.
21.
SchlagheckeRKornelyESantenRTRidderskampP.The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotrophin-releasing hormone. New Engl J Med1992; 326: 226–30.
